Edgemoor Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,618
Closed -$311K 159
2022
Q4
$311K Buy
+3,618
New +$287K 0.04% 131
2018
Q4
Sell
-3,035
Closed -$234K 131
2018
Q3
$234K Sell
3,035
-1,265
-29% -$95.5K 0.03% 126
2018
Q2
$305K Sell
4,300
-126,027
-97% -$8.9M 0.04% 110
2018
Q1
$9.82M Sell
130,327
-2,056
-2% -$163K 1.31% 27
2017
Q4
$10.6M Sell
132,383
-5,312
-4% -$403K 1.34% 27
2017
Q3
$11.2M Sell
137,695
-923
-0.7% -$70.6K 1.51% 22
2017
Q2
$9.82M Sell
138,618
-3,045
-2% -$203K 1.34% 28
2017
Q1
$9.62M Sell
141,663
-8,165
-5% -$574K 1.37% 30
2016
Q4
$10.7M Sell
149,828
-17,350
-10% -$1.29M 1.63% 21
2016
Q3
$13.2M Sell
167,178
-7,080
-4% -$575K 2.04% 12
2016
Q2
$14.5M Buy
174,258
+1,767
+1% +$157K 2.3% 10
2016
Q1
$15.8M Sell
172,491
-3,772
-2% -$340K 2.47% 9
2015
Q4
$17.8M Buy
176,263
+1,857
+1% +$193K 2.68% 8
2015
Q3
$17.1M Sell
174,406
-2,088
-1% -$232K 2.61% 10
2015
Q2
$20.7M Buy
176,494
+1,831
+1% +$200K 3.01% 6
2015
Q1
$17.1M Buy
174,663
+9,810
+6% +$996K 2.43% 12
2014
Q4
$15.6M Buy
164,853
+10,508
+7% +$1.09M 2.28% 13
2014
Q3
$16.4M Buy
154,345
+2,970
+2% +$291K 2.41% 9
2014
Q2
$12.6M Buy
151,375
+141,675
+1,461% +$11M 1.85% 15
2014
Q1
$687K Sell
9,700
-415
-4% -$32.5K 0.11% 90
2013
Q4
$760K Buy
10,115
+415
+4% +$28.9K 0.12% 90
2013
Q3
$610K Hold
9,700
0.11% 95
2013
Q2
$497K Buy
+9,700
New +$506K 0.09% 107

Other funds holding GILD

Edgemoor Investment Advisors's GILD Position: Q1 2023 in Review

Edgemoor Investment Advisors sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 3,618 shares — an estimated $311K sold.

Edgemoor Investment Advisors first reported a position in GILD in Q2 2013 and held it in 23 quarters. The position peaked at $20.7M in Q2 2015. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

  • Edgemoor Investment Advisors reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
  • Edgemoor Investment Advisors sold 3,618 Gilead Sciences shares in Q1 2023, an estimated $311K.
  • Edgemoor Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 23 quarters.
  • Edgemoor Investment Advisors's Gilead Sciences position peaked at $20.7M in Q2 2015.
  • 1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Edgemoor Investment Advisors's 13F filing for Q1 2023, filed 9 May 2023.